Plasma levels of DSIP in infants in the first year of life and SIDS risk.
In searching for abnormalities related to the sudden infant death syndrome (SIDS), delta sleep-inducing peptide (DSIP), a regulatory peptide with sleep promoting actions, was investigated in the first year of life in four groups of children: (1) preterm infants (n = 28), (2) infants with a high mean apnea duration evaluated polysomnographically (n = 26), (3) healthy full-term infants (n = 37) and (4) siblings of SIDS-victims (n = 26). DSIP was radioimmunoassayed in plasma. Half of the infants were also investigated polygraphically during sleep. The ratio between quiet sleep and active sleep was determined. There was no age dependence of the plasma level of DSIP in the first year of life but there was an increase in the ratio of quiet/active sleep depending of maturity. The level of DSIP in healthy full-term infants was significantly higher (P less than 0.05) (median: 1885 pmol/l, interquartile range: 757 pmol/l) than in preterms (1595; 385) and in infants with a high mean apnea duration (1542; 373). There was no significant difference in DSIP concentrations between healthy full-term infants and SIDS-siblings (1605; 271).
Scholle
S
S
University Clinics, Department of Pediatrics, Jena, Germany.
Zwacka
G
G
Ekman
R
R
Glaser
S
S
D000367:Age Factors; D003701:Delta Sleep-Inducing Peptide / Q000097:blood*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D012306:Risk; D012890:Sleep; D013398:Sudden Infant Death / Q000097:blood* / Q000209:etiology
D003701:Delta Sleep-Inducing Peptide